Mirror Review
November 11, 2026
Oura has entered into a definitive agreement to acquire Counsel Health for $625 million in cash, subject to purchase price adjustments, bringing AI-powered medical guidance and access to physicians into its wearable health platform. Announced on November 10, 2026, the Oura Counsel Health acquisition is expected to close before the end of the year, subject to customary closing conditions.
The Oura Counsel Health deal agreement builds on an existing partnership between the two companies. Counsel’s medical AI is already available to Oura members through the Oura App, where users can seek personalized medical guidance and connect with a board-certified physician when needed.
The Oura acquisition of Counsel Health brings together Oura’s continuous biometric data and Counsel’s AI-supported primary care platform. It also gives Oura access to Counsel’s enterprise relationships with health plans, health systems, consumer health organizations, and employers.
Why Is Oura Buying Counsel Health for $625 Million?
Oura is buying Counsel Health to connect wearable health insights with medical guidance and physician-led care. Oura members can use Counsel’s medical AI to discuss health concerns, review information from connected medical records, and seek guidance informed by their biometric data.
When a user needs additional support, the conversation can be escalated to a board-certified Counsel physician. Physicians can provide diagnoses, prescriptions, and referrals when appropriate.
Oura CEO Tom Hale explained the purpose of the acquisition in the official announcement:
“Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals.”
The Oura Counsel Health acquisition also follows a strong financial performance for Oura. For the quarter ended September 30, 2026, the company reported:
- $533 million in quarterly revenue, up 153% year over year.
- $87 million in adjusted EBITDA, representing a 16% margin.
- Approximately $1.75 billion in fiscal 2026 revenue, up 92% year over year.
- More than 6 million members.
Oura identified these financial figures as preliminary and unaudited in its announcement.
How Does Counsel Health’s AI-Powered Primary Care Platform Work?
Counsel Health is an AI-native primary care company founded by physicians and AI researchers. Its platform combines medical AI with in-house physicians to provide medical guidance and access to clinical care.
The Counsel Health AI primary care platform uses connected medical records, previous interactions, evidence-based clinical guidelines, and continuous biometric data to provide personalized guidance. Its clinical AI system also uses specialized agents for tasks such as medical history-taking, medical guideline retrieval, records review, and emergency detection.
Users can begin by chatting with Counsel’s medical AI and choose to add a physician at any point in the conversation. Counsel physicians can provide diagnoses, prescriptions, and referrals when appropriate.
Counsel also serves organizations through enterprise partnerships. These include health plans, health systems, consumer health organizations, and employers. Following the acquisition, Counsel will continue serving existing and new enterprise partners.
How Does the Oura Counsel Health Partnership Work?
The Oura Counsel Health partnership began before the acquisition announcement. In June 2026, the companies began rolling out Counsel’s medical AI experience through Oura Labs in the Oura App. The integration is available to eligible Oura members in 43 U.S. states.
The integration allows members to move from an Oura health insight to a conversation with Counsel’s medical AI. For example, a member who notices changes in sleep or other tracked health metrics can use the service to discuss a concern and receive medical guidance. If necessary, the member can connect with a board-certified physician.
The service uses Oura data only when members consent to sharing it with Counsel. Members can also choose whether to allow Counsel to share health information back with Oura.
The Oura AI healthcare acquisition builds on this existing integration rather than introducing an entirely new service. It allows the companies to expand the connection between wearable health information and clinical care.
How Does the Oura AI Healthcare Expansion Extend Beyond Wearables?
The Oura AI healthcare expansion will focus on three areas: preventive care, acute care, and specialty and chronic care.
- Preventive care: Using continuous health monitoring to help members identify potential changes and seek clinical guidance.
- Acute care: Connecting members with medical AI and physicians for timely support with immediate health concerns.
- Specialty and chronic care: Supporting ongoing health needs, including reproductive health, aging, and cardiometabolic health.
The Oura Counsel Health deal also expands Oura’s reach beyond its existing membership. Counsel’s enterprise partnerships provide a route to serving people through health plans, healthcare organizations, and employers.
The Oura acquisition of Counsel Health adds a clinical care platform and established enterprise relationships to Oura’s wearable technology business.
How Could the Oura Counsel Health Deal Shape AI-Powered Healthcare?
The Oura Counsel Health deal brings continuous biometric information into a medical AI experience that includes access to physicians. This gives clinicians additional health context when reviewing a member’s concerns.
Counsel CEO Muthu Alagappan described the role of that information in the official announcement:
“Continuous health context makes medical AI more useful and relevant by delivering guidance that is personalized to each person’s health.”
The companies’ approach keeps physicians involved in clinical decisions. Counsel’s AI can organize health information and provide guidance, while physicians can assess patients and make clinical decisions when required.
The Oura acquisition of Counsel Health also highlights an important distinction between health tracking and medical care. Oura states that the Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent medical conditions or illnesses. Counsel’s physician-supported service adds a separate route for users seeking medical guidance.
When Will the Oura Counsel Health Acquisition Close?
The Oura Counsel Health acquisition is expected to close before the end of 2026, subject to customary closing conditions. Until the transaction closes, it remains an announced acquisition agreement.
Following the completion of the Oura Counsel Health deal, Counsel is expected to continue serving existing and new enterprise partners. Oura and Counsel plan to expand their combined services across preventive, acute, specialty, and chronic care.
The Oura acquisition 2026 announcement marks a significant step in the company’s expansion from wearable health tracking into AI-supported healthcare services. By acquiring Counsel Health, Oura is bringing biometric data, medical AI, and physician access closer together within its health platform.
Gurushanth S Jatti
